MX2022013147A - Anticuerpos anti-interleucina 31 de acción prolongada para uso veterinario. - Google Patents
Anticuerpos anti-interleucina 31 de acción prolongada para uso veterinario.Info
- Publication number
- MX2022013147A MX2022013147A MX2022013147A MX2022013147A MX2022013147A MX 2022013147 A MX2022013147 A MX 2022013147A MX 2022013147 A MX2022013147 A MX 2022013147A MX 2022013147 A MX2022013147 A MX 2022013147A MX 2022013147 A MX2022013147 A MX 2022013147A
- Authority
- MX
- Mexico
- Prior art keywords
- antibodies
- long
- acting anti
- veterinary use
- acting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063014033P | 2020-04-22 | 2020-04-22 | |
| US202063014549P | 2020-04-23 | 2020-04-23 | |
| PCT/US2021/028548 WO2021216810A1 (en) | 2020-04-22 | 2021-04-22 | Long-acting anti-il31 antibodies for veterinary use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022013147A true MX2022013147A (es) | 2023-02-09 |
Family
ID=78269992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022013147A MX2022013147A (es) | 2020-04-22 | 2021-04-22 | Anticuerpos anti-interleucina 31 de acción prolongada para uso veterinario. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230312702A1 (https=) |
| EP (1) | EP4138914A4 (https=) |
| JP (1) | JP2023524643A (https=) |
| KR (1) | KR20230005875A (https=) |
| CN (1) | CN115666644A (https=) |
| AU (1) | AU2021258198A1 (https=) |
| BR (1) | BR112022021216A2 (https=) |
| CA (1) | CA3173864A1 (https=) |
| MX (1) | MX2022013147A (https=) |
| WO (1) | WO2021216810A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| US12297272B2 (en) | 2017-08-15 | 2025-05-13 | Eianco US inc. | IgG Fc variants for veterinary use |
| US20210388053A1 (en) * | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| US20240209096A1 (en) * | 2022-12-27 | 2024-06-27 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| GB202405576D0 (en) * | 2024-04-19 | 2024-06-05 | 272Bio Ltd | VHH antibodies |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102057826B1 (ko) * | 2008-04-11 | 2019-12-20 | 추가이 세이야쿠 가부시키가이샤 | 복수 분자의 항원에 반복 결합하는 항원 결합 분자 |
| US20200181258A1 (en) * | 2016-10-17 | 2020-06-11 | Vetoquinol Sa | Modified antibody constant region |
| WO2018156367A1 (en) * | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| US10093731B2 (en) * | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| US12297272B2 (en) * | 2017-08-15 | 2025-05-13 | Eianco US inc. | IgG Fc variants for veterinary use |
| CA3093539A1 (en) * | 2018-03-16 | 2019-09-19 | Zoetis Services Llc | Interleukin-31 monoclonal antibodies for veterinary use |
| US20210388053A1 (en) * | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| CN113544153B (zh) * | 2019-01-03 | 2024-12-10 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| US20220169740A1 (en) * | 2019-03-20 | 2022-06-02 | Kindred Biosciences, Inc. | NGF Antagonists for Medical Use |
| MX2022011335A (es) * | 2020-03-18 | 2022-10-07 | Kindred Biosciences Inc | Anticuerpos del receptor anti-interleucina 4 para uso veterinario. |
-
2021
- 2021-04-22 KR KR1020227039975A patent/KR20230005875A/ko active Pending
- 2021-04-22 US US17/996,557 patent/US20230312702A1/en active Pending
- 2021-04-22 BR BR112022021216A patent/BR112022021216A2/pt unknown
- 2021-04-22 MX MX2022013147A patent/MX2022013147A/es unknown
- 2021-04-22 WO PCT/US2021/028548 patent/WO2021216810A1/en not_active Ceased
- 2021-04-22 AU AU2021258198A patent/AU2021258198A1/en active Pending
- 2021-04-22 EP EP21792891.0A patent/EP4138914A4/en active Pending
- 2021-04-22 JP JP2022563136A patent/JP2023524643A/ja active Pending
- 2021-04-22 CN CN202180036332.3A patent/CN115666644A/zh active Pending
- 2021-04-22 CA CA3173864A patent/CA3173864A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3173864A1 (en) | 2021-10-28 |
| EP4138914A1 (en) | 2023-03-01 |
| WO2021216810A1 (en) | 2021-10-28 |
| EP4138914A4 (en) | 2024-05-22 |
| US20230312702A1 (en) | 2023-10-05 |
| AU2021258198A1 (en) | 2022-11-17 |
| CN115666644A (zh) | 2023-01-31 |
| KR20230005875A (ko) | 2023-01-10 |
| BR112022021216A2 (pt) | 2022-12-06 |
| JP2023524643A (ja) | 2023-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022013147A (es) | Anticuerpos anti-interleucina 31 de acción prolongada para uso veterinario. | |
| MX2024012304A (es) | Anticuerpos anti-il31 para uso veterinario | |
| MX2022002360A (es) | Anticuerpos de anti-il31 para uso veterinario. | |
| Roche et al. | A 100-year review: a century of change in temperate grazing dairy systems | |
| MX2022013149A (es) | Moléculas receptoras de interleucina 4/interleucina 13 para uso veterinario. | |
| NZ757956A (en) | Il4/il13 receptor molecule for veterinary use | |
| MX2022011335A (es) | Anticuerpos del receptor anti-interleucina 4 para uso veterinario. | |
| BR112022020495A2 (pt) | Composições compreendendo algas e métodos de uso das mesmas para aumentar a produção de produto animal | |
| MX2021011335A (es) | Antagonistas de ngf para uso medicinal. | |
| MX377475B (es) | Anticuerpo monoclonal de interleucina-31. | |
| BR112015031719A2 (pt) | método para preparar aditivo de ração | |
| MX393522B (es) | Mejoras al desempeño del crecimiento en sistemas de alimentación por pastoreo y en corrales de engorda. | |
| HN2004000023A (es) | Mascadura para animales | |
| MX2009005965A (es) | Composiciones de alimento para animales. | |
| Martínez-Navarro | Oldowan scavengers vs. Acheulian hunters: what does the faunal record say? | |
| Fijn | The domestic and the wild in the Mongolian horse and the takhi | |
| RU2013144785A (ru) | Способ повышения репродуктивных качеств свиноматок | |
| MX2024007091A (es) | Anticuerpos caninizados y felinizados contra el ngf humano. | |
| PL4312528T3 (pl) | System i sposób dostarczania pokarmu gatunkowi zwierząt | |
| Orihuela et al. | Close contact with spontaneously cycling Saint Croix ewes triggers cyclic activity in seasonally anestrous Suffolk ewes | |
| MX2024002535A (es) | Procedimiento para mejorar la ingesta de alimentos. | |
| NZ752360A (en) | Nutrient loss reduction method | |
| Sawada et al. | Plasma 3-methylhistidine concentration in peripartum dairy cows given diets with two protein levels | |
| Triebe et al. | Tagasaste versus Golden Bamboo: Which do horses prefer? | |
| Gebreyesus et al. | Evaluation of growth trends in the short-eared Somali goat breed of eastern Ethiopia |